Literature DB >> 7842468

Transient beta adrenergic stimulation can precondition the rat heart against postischaemic contractile dysfunction.

G K Asimakis1, K Inners-McBride, V R Conti, C J Yang.   

Abstract

OBJECTIVE: The aim was to assess the abilities of exogenous noradrenaline, isoprenaline, and phenylephrine to precondition the isolated rat heart against ischaemic and reperfusion injury.
METHODS: The isovolumetric Langendorff rat heart model was used to determine postischaemic recovery of left ventricular function. The hearts were subjected to 30 min of normothermic global ischaemia followed by 30 min reperfusion. Treated hearts were perfused with noradrenaline (10(-7) M), isoprenaline (10(-8) M), or phenylephrine (10(-6) M, 10(-5) M, and 10(-4) M) for 5 min followed by 5 min washout before the 30 min ischaemic period.
RESULTS: Control hearts recovered 47.6(SEM 4.3)% of baseline heart rate x developed pressure after 30 min reperfusion, whereas noradrenaline and isoprenaline treated hearts recovered 75.1(4.6) and 76.4(4.6)%, respectively (p < 0.001 v control). Left ventricular end diastolic pressures at the end of reperfusion were 48.8(4.0), 20.0(2.4), and 21.6(2.7)mm Hg for control, noradrenaline treated (p < 0.001 v control), and isoprenaline treated (p < 0.001 v control) hearts respectively. beta Blockade with propranolol during noradrenaline treatment blocked the protective effects. No concentration of phenylephrine used was able to enhance postischaemic heart rate x developed pressure significantly, or result in improved (lower) postischaemic left ventricular end diastolic pressure. During treatment with noradrenaline and phenylephrine (10(-5) M), lactate release was 13.0(1.0) and 11.0(0.9) mumol.5 min-1, respectively (p = NS); these values were significantly (p < 0.001) greater than baseline value of 3.7(0.5) mumol.5 min-1. Immediately before the 30 min ischaemic period, control and phenylephrine treated groups had glycogen levels of 132(14) and 128(5) nmol.mg-1 protein, respectively (p = NS), whereas the glycogen content of the noradrenaline treated group was only 96(5) nmol.mg-1 protein (p < 0.05 v control and phenylephrine treated).
CONCLUSIONS: Transient beta adrenergic but not alpha 1 adrenergic stimulation can precondition the isolated perfused rat heart. The mechanism of protection may, at least in part, be due to transient demand ischaemia. Partial depletion of glycogen following treatment may play a role in the observed protective effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7842468     DOI: 10.1093/cvr/28.11.1726

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  9 in total

1.  Mechanisms whereby glucose deprivation triggers metabolic preconditioning in the isolated rat heart.

Authors:  M M Awan; S Makaula; S Forresti; M N Sack; L H Opie
Journal:  Mol Cell Biochem       Date:  2000-08       Impact factor: 3.396

2.  The antiarrhythmic effects of ischaemic preconditioning in anaesthetized dogs are prevented by atropine; role of changes in baroreceptor reflex sensitivity.

Authors:  László Babai; Julius Gy Papp; James R Parratt; Agnes Végh
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  Does glycogen depletion play an important role in ischemic preconditioning?

Authors:  K Yabe; S Takeo
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

4.  The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism.

Authors:  Tommaso Angelone; Anna Maria Quintieri; Bhawanjit K Brar; Pauline T Limchaiyawat; Bruno Tota; Sushil K Mahata; Maria Carmela Cerra
Journal:  Endocrinology       Date:  2008-06-05       Impact factor: 4.736

5.  Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning.

Authors:  A Lochner; S Genade; E Tromp; L Opie; J Moolman; S Thomas; T Podzuweit
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

6.  Consecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioning.

Authors:  Igor Khaliulin; Joanna E Parker; Andrew P Halestrap
Journal:  Cardiovasc Res       Date:  2010-06-16       Impact factor: 10.787

7.  Functional and cardioprotective effects of simultaneous and individual activation of protein kinase A and Epac.

Authors:  Igor Khaliulin; Mark Bond; Andrew F James; Zara Dyar; Raheleh Amini; Jason L Johnson; M-Saadeh Suleiman
Journal:  Br J Pharmacol       Date:  2017-02-14       Impact factor: 8.739

Review 8.  Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.

Authors:  A Lochner; E Marais; S Genade; B Huisamen; E F du Toit; J A Moolman
Journal:  Cardiovasc J Afr       Date:  2009 Jan-Feb       Impact factor: 1.167

9.  Consecutive Isoproterenol and Adenosine Treatment Confers Marked Protection against Reperfusion Injury in Adult but Not in Immature Heart: A Role for Glycogen.

Authors:  Martin Lewis; Adrian Szobi; Dirki Balaska; Igor Khaliulin; Adriana Adameova; Elinor Griffiths; Clive H Orchard; M-Saadeh Suleiman
Journal:  Int J Mol Sci       Date:  2018-02-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.